Clinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophrenia.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3560721)

Published in Med Sci Monit on June 01, 2012

Authors

Agata Szulc1, Beata Galińska-Skok, Eugeniusz Tarasów, Beata Konarzewska, Napoleon Waszkiewicz, Rafał Hykiel, Jerzy Walecki

Author Affiliations

1: Psychiatry Clinic of Medical University of Bialystok, Bialystok, Poland. agataszulc@poczta.onet.pl

Articles cited by this

The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07

A review of MRI findings in schizophrenia. Schizophr Res (2001) 8.95

The relation of the trail making test to organic brain damage. J Consult Psychol (1955) 4.33

"Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull (1998) 3.67

The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res (2004) 1.87

Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients. Neuroimage (2002) 1.83

Magnetic resonance spectroscopy in cognitive research. Brain Res Brain Res Rev (2004) 1.42

Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation. Schizophr Res (2001) 1.30

Sex differences in N-acetylaspartate correlates of general intelligence: an 1H-MRS study of normal human brain. Neuroimage (2005) 1.30

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry (1997) 1.28

Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry (2000) 1.28

The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry (2001) 1.22

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J Psychiatr Res (2006) 1.22

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res (2003) 1.20

Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage (2003) 1.18

Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis. Biol Psychiatry (2010) 1.11

Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett (2005) 1.09

The membrane hypothesis of schizophrenia. Schizophr Res (1994) 1.08

N-acetylaspartate levels of left frontal cortex are associated with verbal intelligence in women but not in men: a proton magnetic resonance spectroscopy study. Neuroscience (2004) 1.03

The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS). Pharmacopsychiatry (2005) 1.02

A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging (1999) 1.01

Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report. Am J Psychiatry (2000) 1.01

Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biol Psychiatry (2003) 1.01

Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study. Neuroimage (2009) 1.00

A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol Psychiatry (1999) 0.98

Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy. Schizophr Res (2008) 0.95

Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Invest Radiol (1996) 0.95

Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Psychiatry Clin Neurosci (2006) 0.95

Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Arch Neurol (2002) 0.94

1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. Neuroimage (2004) 0.92

Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. Am J Psychiatry (2003) 0.92

Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment. Pharmacopsychiatry (2011) 0.91

High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia. Am J Psychiatry (2002) 0.91

Brain metabolite concentrations across cortical regions in healthy adults. Brain Res (2010) 0.91

Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophr Res (2002) 0.86

Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy. Psychiatry Res (2000) 0.85

Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: a replication study. Am J Psychiatry (2001) 0.84

Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. Am J Psychiatry (2000) 0.84

The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Neuroradiology (2003) 0.83

Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Psychiatry Res (2004) 0.82

Relationship between performance on the Stroop test and N-acetylaspartate in the medial prefrontal cortex in deficit and nondeficit schizophrenia: preliminary results. Psychiatry Res (2004) 0.81

Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy. Psychiatry Res (1999) 0.81

Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia. Med Sci Monit (2007) 0.79

[Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients]. Psychiatr Pol (2004) 0.79

Heritability heightens brain metabolite differences in schizophrenia. J Neuropsychiatry Clin Neurosci (2000) 0.79

[Working memory: neuropsychological and neurobiological issues]. Psychiatr Pol (2006) 0.76

MR proton spectroscopy in patients with CNS involvement in Bourneville's disease. Med Sci Monit (2001) 0.76

Articles by these authors

The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic: a randomized controlled study. Pancreas (2010) 2.28

1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys (2002) 1.69

Development of molecular imaging in the European radiological community. Eur Radiol (2009) 1.08

[Biomarkers of alcohol abuse. Part II. New biomarkers and their interpretation]. Psychiatr Pol (2010) 0.99

Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Psychoneuroendocrinology (2008) 0.98

Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC. Liver Int (2014) 0.98

Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia. Med Sci Monit (2009) 0.95

Cylindroma transforming into basal cell carcinoma in a patient with Brooke-Spiegler syndrome. J Dermatol Case Rep (2007) 0.90

Cyst-like cortical tubers in patients with tuberous sclerosis complex: MR imaging with the FLAIR sequence. Pediatr Radiol (2006) 0.90

Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method. Acad Radiol (2003) 0.88

MR proton spectroscopy in liver examinations of healthy individuals in vivo. Med Sci Monit (2002) 0.87

Measurements of the middle cerebral artery in digital subtraction angiography and MR angiography. Med Sci Monit (2007) 0.87

The comparison of efficacy of different imaging techniques (conventional radiography, ultrasonography, magnetic resonance) in assessment of wrist joints and metacarpophalangeal joints in patients with psoriatic arthritis. Pol J Radiol (2013) 0.87

Proton magnetic resonance spectroscopy changes after antipsychotic treatment. Curr Med Chem (2013) 0.86

Magnetic resonance imaging in the evaluation of the fetal spinal canal contents. Brain Dev (2010) 0.85

The clinical value of MRI using single-shot echoplanar DWI to identify liver involvement in patients with advanced gastroenteropancreatic-neuroendocrine tumors (GEP-NETs), compared to FSE T2 and FFE T1 weighted image after i.v. Gd-EOB-DTPA contrast enhancement. Med Sci Monit (2012) 0.85

Spastic cerebral palsy: clinical magnetic resonance imaging correlation of 129 children. J Child Neurol (2007) 0.85

Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation. Med Sci Monit (2004) 0.84

Automatic detection, localization, and volume estimation of ischemic infarcts in noncontrast computed tomographic scans: method and preliminary results. Invest Radiol (2013) 0.84

N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study. Med Sci Monit (2007) 0.84

Retinol binding protein-4 as a serum biomarker of intrahepatic lipid content in obese children--preliminary report. Acta Biochim Pol (2011) 0.84

Psoriatic arthritis. Pol J Radiol (2013) 0.84

Corpus callosum size in children with spastic cerebral palsy: relationship to clinical outcome. J Child Neurol (2007) 0.83

Vasculitis and stroke due to Lyme neuroborreliosis - a review. Infect Dis (Lond) (2014) 0.83

Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia. Neurosci Lett (2013) 0.83

Interstitial deletion 9q22.32-q33.2 associated with additional familial translocation t(9;17)(q34.11;p11.2) in a patient with Gorlin-Goltz syndrome and features of Nail-Patella syndrome. Am J Med Genet A (2004) 0.83

Binge drinking-induced liver injury. Hepatology (2009) 0.82

The effect of chronic alcohol intoxication and smoking on the output of salivary immunoglobulin A. Folia Histochem Cytobiol (2012) 0.82

Carbohydrate markers of pancreatic cancer. Biochem Soc Trans (2011) 0.82

Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver. Med Sci Monit (2004) 0.82

MR spectroscopy in patients after surgical clipping and endovascular embolisation of intracranial aneurysms. Pol J Radiol (2010) 0.81

Congenital brain tumors in a series of 56 patients. Childs Nerv Syst (2012) 0.80

Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia. Med Sci Monit (2007) 0.79

[Family history of alcohol abuse - depressive symptoms and the quality of life in view of the MAST score of schizophrenic patients with dual diagnosis]. Pol Merkur Lekarski (2012) 0.79

Impact of salivary flow and lysozyme content and output on the oral health of rheumatoid arthritis patients. Postepy Hig Med Dosw (Online) (2011) 0.79

Alcohol abuse and glycoconjugate metabolism. Folia Histochem Cytobiol (2012) 0.79

Magnetic resonance imaging of brain abnormalities in patients with the Nijmegen breakage syndrome. Acta Neurobiol Exp (Wars) (2004) 0.79

Salivary innate defense system in type 1 diabetes mellitus in children with mixed and permanent dentition. Acta Odontol Scand (2013) 0.79

Catabolism of salivary glycoconjugates in acute ethanol intoxication. Med Sci Monit (2009) 0.79

[Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients]. Psychiatr Pol (2004) 0.79

Prediction of deterioration of mild cognitive impairment with CT and SPECT. Med Sci Monit (2007) 0.79

Rheumatoid arthritis patients with xerostomia have reduced production of key salivary constituents. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.79

[Psychoactive plant species--actual list of plants prohibited in Poland]. Psychiatr Pol (2013) 0.78

[The influence of atypical antipsychotics on brain functioning in schizophrenia. A proton magnetic resonance study]. Psychiatr Pol (2010) 0.78

A comparison of spastic diplegic and tetraplegic cerebral palsy. Pediatr Neurol (2005) 0.78

[Activity of N-acetyl-β-hexosaminidase and its isoenzymes A and B in cancer]. Postepy Hig Med Dosw (Online) (2011) 0.78

Proton magnetic resonance spectroscopy in children with spastic diplegia. Neurosci Lett (2004) 0.78

[Activity of cathepsin D in the blood serum and urine of patients with cancer of the stomach, pancreas and liver]. Pol Arch Med Wewn (2006) 0.78

[Biomarkers of alcohol abuse. Part I. Traditional biomarkers and their interpretation]. Psychiatr Pol (2010) 0.78

Salivary lysosomal exoglycosidases profiles in patients with insulin-dependent and noninsulin-dependent diabetes mellitus. Adv Clin Exp Med (2013) 0.78

Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland. Neuro Endocrinol Lett (2007) 0.78

The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity. Diabetes Care (2013) 0.78

Diagnostic imaging of carcinoid metastases to the abdomen and pelvis. Med Sci Monit (2004) 0.78

Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study. Dev Med Child Neurol (2006) 0.78

[Alcohol and psychiatric disorders]. Pol Merkur Lekarski (2012) 0.78

Salivary: flow and proteins of the innate and adaptive immunity in the limited and diffused systemic sclerosis. J Oral Pathol Med (2014) 0.78

The usefulness of diffusion-weighted/fluid-attenuated inversion recovery imaging in the diagnostics and timing of lacunar and nonlacunar stroke. Neuroradiology (2014) 0.78

MR in neurological syndromes of connective tissue diseases. Med Sci Monit (2002) 0.77

Underappreciated role of binge drinking in the risk of lung cancer. Eur J Public Health (2009) 0.77

Common carotid artery dissection in the course of acute aortic dissection De Bakey type I. Neurol Neurochir Pol (2007) 0.77

Lysosomal exoglycosidases in serum and urine of patients with pancreatic adenocarcinoma. Folia Histochem Cytobiol (2010) 0.77

[Functioning of the marriages applying for marital therapy]. Psychiatr Pol (2013) 0.77

[The influence of alcohol on the oral cavity, salivary glands and saliva]. Pol Merkur Lekarski (2011) 0.77

Decrease in salivary lactoferrin output in chronically intoxicated alcohol-dependent patients. Folia Histochem Cytobiol (2012) 0.77

Urinary fructose-1,6-bisphosphatase activity as a marker of the damage to the renal proximal tubules in children with idiopathic nephrotic syndrome. Clin Chem Lab Med (2008) 0.77

[The central nervous system and HIV infection]. Neurol Neurochir Pol (2003) 0.77

Exoglycosidase markers of diseases. Biochem Soc Trans (2011) 0.76

The effect of chronic alcohol intoxication and smoking on the activity of oral peroxidase. Folia Histochem Cytobiol (2012) 0.76

Changes in the fibrinolytic system during angiography with ionic and with nonionic contrast media. Acad Radiol (2002) 0.76

Cerebral circulation insufficiency - correlation of CTA-visualized atherosclerotic lesions in extra- and intracranial arteries. Med Sci Monit (2004) 0.76

The salivary β-HEX A% index as an excellent marker of periodontitis in smoking alcohol-dependent persons. Dis Markers (2013) 0.76

Salivary antioxidants in patients with systemic sclerosis. J Oral Pathol Med (2013) 0.76

Glycosylation changes in the salivary glycoproteins of alcohol-dependent patients: a pilot study. Alcohol Alcohol (2013) 0.76

Activity of N-acetyl-β-D-hexosaminidase in the saliva of children with type 1 diabetes. Postepy Hig Med Dosw (Online) (2013) 0.76

Plasma carnitine concentrations after chronic alcohol intoxication. Postepy Hig Med Dosw (Online) (2013) 0.76

[Biology of essential fatty acids (EFA)]. Przegl Lek (2007) 0.76

[The effectiveness of psychoeducation in schizophrenic and depressive patients--preliminary report]. Psychiatr Pol (2004) 0.76

Stabilizing the urinary activity of fructose-1,6-bisphosphatase with EDTA and mercaptoethanol. Clin Biochem (2009) 0.76

Shoulder joint tuberculosis. Pol J Radiol (2012) 0.75

Reducing binge drinking harm in middle-aged and elderly adults. Am J Psychiatry (2010) 0.75

Proton MR spectroscopy in mild traumatic brain injury. Pol J Radiol (2010) 0.75

Usefulness of corregistration and post-processing of MR and interictal SPECT images for localization of epileptogenic focus in children - preliminary report. Pol J Radiol (2011) 0.75

Preoperative ultrasonographic examination of the radial artery and the cephalic vein and risks of dialysis arterio-venous fistula dysfunction. Pol J Radiol (2010) 0.75

Usefulness of computed tomography virtual bronchoscopy in the evaluation of bronchi divisions. Pol J Radiol (2013) 0.75

Alpha fucosidase and beta galactosidase in serum of a Lyme disease patients as a possible marker of accelerated senescence - a preliminary study. Folia Histochem Cytobiol (2012) 0.75

Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs. J Nucl Med (2008) 0.75

Thyroid volume and hormone response in the early kidney transplants. Med Sci Monit (2004) 0.75

Contrast-enhanced, wide-band phase-inversion power Doppler imaging of hepatic focal nodular hyperplasia. Hepatogastroenterology (2004) 0.75